JNK-IN-15, Cell-Permeable

• UNSPSC Description:

  JNK-IN-15, Cell-Permeable (JNK inhibitor III) is an inhibitor of JNK. JNK-IN-15, Cell-Permeable can used in study age-related neurodegenerative diseasev[1].

• Target Antigen:

  JNK

• Type:

  Peptides

• Related Pathways:

  MAPK/ERK Pathway

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/jnk-in-15-cell-permeable.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CCCNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC(C)=O)CC1=CC=C(O)C=C1)=O)=O)CCCNC(N)=N)=O)CCCCN)=O)CCCCN)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC(N)=O)=O)CCCCN)=O)C)=O)CCCNC(N)=N)=O)CC(C)C)=O)CC4=CNC=N4)=O)CCC3)=O)CCCCN)=O)CC(C)C)=O)CO)=O)=O)C(C)C)=O)CCC2)=O)CC(O)=O)=O)C)=O)CC(C)C)=O)CC(N)=O)=O)CC(C)C)=O)[C@@H](C)O)=O)CCSC)=O)CO)=O)CCC(N)=O)=O)CCCCN)=O)CC(C)C)=O)[C@H](CC)C

• Molecular Weight:

  4413.22

• References & Citations:

  [1]Guha I, et al. The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons. Neurobiol Aging. 2016 Oct;46:138-48.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported